Golden Biotechnology Corporation Share Price
Equities
4132
TW0004132006
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.9 TWD | -0.52% | +2.30% | -26.37% |
Sales 2021 | 81.77M 2.51M 209M | Sales 2022 | 218M 6.69M 557M | Capitalization | 8.55B 262M 21.88B |
---|---|---|---|---|---|
Net income 2021 | -444M -13.63M -1.14B | Net income 2022 | -272M -8.35M -696M | EV / Sales 2021 | 204 x |
Net cash position 2021 | 438M 13.46M 1.12B | Net cash position 2022 | 239M 7.33M 612M | EV / Sales 2022 | 38.1 x |
P/E ratio 2021 |
-38.7
x | P/E ratio 2022 |
-31.4
x | Employees | 122 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 100% |
1 day | -0.52% | ||
1 week | +2.30% | ||
Current month | -9.55% | ||
1 month | -7.07% | ||
3 months | -20.06% | ||
6 months | -14.12% | ||
Current year | -26.37% |
Managers | Title | Age | Since |
---|---|---|---|
Ching Tien Su
CEO | Chief Executive Officer | - | 04/19/04 |
Li Yue Wu
FOU | Founder | - | 27/02/27 |
Mu Tseng Tseng
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Sheng Yung Liu
FOU | Founder | - | 27/02/27 |
Li Yue Wu
FOU | Founder | - | 27/02/27 |
Yue Chun Chen
BRD | Director/Board Member | - | 26/09/26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 117 M€ | +1.11% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 28.9 | -0.52% | 169,293 |
25/24/25 | 29.05 | -0.85% | 176,951 |
24/24/24 | 29.3 | +1.91% | 467,853 |
23/24/23 | 28.75 | +0.70% | 321,019 |
22/24/22 | 28.55 | +1.06% | 272,698 |
End-of-day quote Taipei Exchange, April 26, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-26.37% | 126M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 4132 Stock